Europe Biologics and Biosimilars Market Research Report Forecast 2017-2021

March 2017 | 101 pages | ID: E55C920130CEN
S&P Consulting

Abstracts

The Europe Biologics and Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Biologics and Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Biologics and Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Biologics and Biosimilars Market Analysis by Countries :

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

The Major players reported in the market include:
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
company 9
Europe Biologics and Biosimilars Market Analysis by Product :
Biologics
Biosimilars

• Type III

Europe Biologics and Biosimilars Market Analysis by Application:
Tumor
Diabetes
Cardiovascular

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
  1.2.1 Biologics
  1.2.2 Biosimilars
  1.2.3 Type III
1.3 Application of Biologics and Biosimilars
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
1.4 Biologics and Biosimilars Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Biologics and Biosimilars (2012-2021)
  1.5.1 Europe Biologics and Biosimilars Sales and Growth Rate (2012-2021)
  1.5.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON BIOLOGICS AND BIOSIMILARS INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

3.1 Biologics and Biosimilars Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Biologics and Biosimilars

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Biologics and Biosimilars Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Biologics and Biosimilars Market Competition by Manufacturers
  5.1.1 Europe Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Biologics and Biosimilars (Volume and Value) by Type
  5.2.1 Europe Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 Europe Biologics and Biosimilars (Volume and Value) by Countries
  5.3.1 Europe Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
5.4 Europe Biologics and Biosimilars (Volume) by Application

6 GERMANY BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Biologics and Biosimilars Sales and Value (2012-2017)
  6.1.1 Germany Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  6.1.2 Germany Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Biologics and Biosimilars Sales Price Trend (2012-2017)
6.2 Germany Biologics and Biosimilars Sales and Market Share by Manufacturers
6.3 Germany Biologics and Biosimilars Sales and Market Share by Type
6.4 Germany Biologics and Biosimilars Sales and Market Share by Application

7 FRANCE BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 France Biologics and Biosimilars Sales and Value (2012-2017)
  7.1.1 France Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  7.1.2 France Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 France Biologics and Biosimilars Sales Price Trend (2012-2017)
7.2 France Biologics and Biosimilars Sales and Market Share by Manufacturers
7.3 France Biologics and Biosimilars Sales and Market Share by Type
7.4 France Biologics and Biosimilars Sales and Market Share by Application

8 UK BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 UK Biologics and Biosimilars Sales and Value (2012-2017)
  8.1.1 UK Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  8.1.2 UK Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 UK Biologics and Biosimilars Sales Price Trend (2012-2017)
8.2 UK Biologics and Biosimilars Sales and Market Share by Manufacturers
8.3 UK Biologics and Biosimilars Sales and Market Share by Type
8.4 UK Biologics and Biosimilars Sales and Market Share by Application

9 RUSSIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Biologics and Biosimilars Sales and Value (2012-2017)
  9.1.1 Russia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  9.1.2 Russia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Biologics and Biosimilars Sales Price Trend (2012-2017)
9.2 Russia Biologics and Biosimilars Sales and Market Share by Manufacturers
9.3 Russia Biologics and Biosimilars Sales and Market Share by Type
9.4 Russia Biologics and Biosimilars Sales and Market Share by Application

10 ITALY BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Biologics and Biosimilars Sales and Value (2012-2017)
  10.1.1 Italy Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  10.1.2 Italy Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Biologics and Biosimilars Sales Price Trend (2012-2017)
10.2 Italy Biologics and Biosimilars Sales and Market Share by Manufacturers
10.3 Italy Biologics and Biosimilars Sales and Market Share by Type
10.4 Italy Biologics and Biosimilars Sales and Market Share by Application

11 SPAIN BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Biologics and Biosimilars Sales and Value (2012-2017)
  11.1.1 Spain Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  11.1.2 Spain Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Biologics and Biosimilars Sales Price Trend (2012-2017)
11.2 Spain Biologics and Biosimilars Sales and Market Share by Manufacturers
11.3 Spain Biologics and Biosimilars Sales and Market Share by Type
11.4 Spain Biologics and Biosimilars Sales and Market Share by Application

12 BENELUX BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Biologics and Biosimilars Sales and Value (2012-2017)
  12.1.1 Benelux Biologics and Biosimilars Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Biologics and Biosimilars Sales Price Trend (2012-2017)
12.2 Benelux Biologics and Biosimilars Sales and Market Share by Manufacturers
12.3 Benelux Biologics and Biosimilars Sales and Market Share by Type
12.4 Benelux Biologics and Biosimilars Sales and Market Share by Application

13 EUROPE BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Roche
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Amgen
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 AbbVie
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Sanofi
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Johnson & Johnson
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Novo Nordisk
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Novartis
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 company
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview
…

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Biologics and Biosimilars Market Forecast by Type (2017-2021)
15.9 Europe Biologics and Biosimilars Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Europe Sales Market Share of Biologics and Biosimilars by Type in 2015
Table Application of Biologics and Biosimilars
Figure Europe Sales Market Share of Biologics and Biosimilars by Application in 2015
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Benelux Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2012-2021)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2021)
Table Europe Biologics and Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Biologics and Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers
Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers
Table Europe Biologics and Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Biologics and Biosimilars Revenue Share by Manufacturers
Table Europe Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
Table Europe Biologics and Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure Europe Biologics and Biosimilars Sales Growth Rate by Type (2012-2017)
Table Europe Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
Table Europe Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure Europe Biologics and Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Europe Biologics and Biosimilars Sales and Market Share by Countries (2012-2017)
Table Europe Biologics and Biosimilars Sales Share by Countries (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Countries (2012-2017)
Table Europe Biologics and Biosimilars Revenue and Market Share by Countries (2012-2017)
Table Europe Biologics and Biosimilars Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Countries (2012-2017)
Table Europe Biologics and Biosimilars Sales and Market Share by Application (2012-2017)
Table Europe Biologics and Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Application (2012-2017)
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Germany Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Germany Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Germany Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Germany Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Germany Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure France Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure France Biologics and Biosimilars Sales Price Trend (2012-2017)
Table France Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Biologics and Biosimilars Sales by Type (2015 and 2016)
Table France Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table France Biologics and Biosimilars Sales by Application (2015 and 2016)
Table France Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure UK Biologics and Biosimilars Sales Price Trend (2012-2017)
Table UK Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Biologics and Biosimilars Sales by Type (2015 and 2016)
Table UK Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table UK Biologics and Biosimilars Sales by Application (2015 and 2016)
Table UK Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Russia Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Russia Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Russia Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Russia Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Russia Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Italy Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Italy Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Italy Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Italy Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Italy Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Spain Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Spain Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Spain Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Spain Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Spain Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Biologics and Biosimilars Sales and Growth Rate (2012-2017)
Figure Benelux Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Figure Benelux Biologics and Biosimilars Sales Price Trend (2012-2017)
Table Benelux Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Benelux Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Benelux Biologics and Biosimilars Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Biologics and Biosimilars Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Biologics and Biosimilars Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Biologics and Biosimilars Sales Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Biologics and Biosimilars Sales Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Biologics and Biosimilars Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Germany Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure France Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure France Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure UK Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure UK Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table Europe Biologics and Biosimilars Sales Forecast by Type (2017-2021)
Table Europe Biologics and Biosimilars Sales Forecast by Application (2017-2021)